Ngan Lam
Ngan Lam has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Amanda N. Nieman
Promega Corporation
1 shared publicationElizabeth R. Dominguez
Promega Corporation
1 shared publicationJames D. Vasta
Promega Corporation
1 shared publicationJennifer Wilkinson
Promega Corporation
1 shared publicationKaitlin K. Dunn Hoffman
Promega Corporation
1 shared publication- Matthew Brian Robers
Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, USA
1 shared publication
Latest Publications
- 10 August 2023
- Published by Springer Nature
- Vol. 2706, 97-124
NanoBRET™ Live-Cell Kinase Selectivity Profiling Adapted for High-Throughput Screening
Kinases represent one of the most therapeutically tractable targets for drug discovery in the twenty-first century. However, confirming engagement and achieving intracellular kinase selectivity for small-molecule kinase inhibitors can represent noteworthy challenges. The NanoBRETTM platform enables broad-spectrum live-cell kinase selectivity profiling in most laboratory settings, without advanced instrumentation or expertise. However, the prototype workflow for this selectivity profiling is currently limited to manual liquid handling and 96-well plates. Herein, we describe a scalable workflow with automation and acoustic dispensing, thus dramatically improving the throughput. Such adaptations enable profiling of larger compound sets against 192 full-length protein kinases in live cells, with statistical robustness supporting quantitative analysis. Key words BRET NanoBRETTM Kinase profiling High-Throughput Screening (HTS) Live-cell target engagement
- 10 August 2023
- Published by Springer Nature
- Vol. 2706, 97-124
NanoBRET™ Live-Cell Kinase Selectivity Profiling Adapted for High-Throughput Screening
Kinases represent one of the most therapeutically tractable targets for drug discovery in the twenty-first century. However, confirming engagement and achieving intracellular kinase selectivity for small-molecule kinase inhibitors can represent noteworthy challenges. The NanoBRETTM platform enables broad-spectrum live-cell kinase selectivity profiling in most laboratory settings, without advanced instrumentation or expertise. However, the prototype workflow for this selectivity profiling is currently limited to manual liquid handling and 96-well plates. Herein, we describe a scalable workflow with automation and acoustic dispensing, thus dramatically improving the throughput. Such adaptations enable profiling of larger compound sets against 192 full-length protein kinases in live cells, with statistical robustness supporting quantitative analysis. Key words BRET NanoBRETTM Kinase profiling High-Throughput Screening (HTS) Live-cell target engagement